Venook AP - Search Results

1

Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.

Venook AP, Egorin MJ, Rosner GL, Brown TD, Jahan TM, Batist G, Hohl R, Budman D, Ratain MJ, Kearns CM, Schilsky RL. Venook AP, et al. J Clin Oncol. 1998 May;16(5):1811-9. doi: 10.1200/JCO.1998.16.5.1811. J Clin Oncol. 1998. PMID: 9586895 Clinical Trial.

2

Chemoembolization for hepatocellular carcinoma.

Venook AP, Stagg RJ, Lewis BJ, Chase JL, Ring EJ, Maroney TP, Hohn DC. Venook AP, et al. J Clin Oncol. 1990 Jun;8(6):1108-14. doi: 10.1200/JCO.1990.8.6.1108. J Clin Oncol. 1990. PMID: 2161449 Clinical Trial.

3

Treatment of hepatocellular carcinoma: too many options?

Venook AP. Venook AP. J Clin Oncol. 1994 Jun;12(6):1323-34. doi: 10.1200/JCO.1994.12.6.1323. J Clin Oncol. 1994. PMID: 8201395 Review.

4

Update on hepatic intra-arterial chemotherapy.

Venook AP. Venook AP. Oncology (Williston Park). 1997 Jul;11(7):947-57; discussion 961-2, 964, 970. Oncology (Williston Park). 1997. PMID: 9251115 Free article. Review.

5

Tamoxifen in liver disease: potential exacerbation of hepatic dysfunction.

Floren LC, Hebert MF, Venook AP, Jordan VC, Cisneros A, Somberg KA. Floren LC, et al. Among authors: venook ap. Ann Oncol. 1998 Oct;9(10):1123-6. doi: 10.1023/a:1008269025294. Ann Oncol. 1998. PMID: 9834826 Free article.

6

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ. Venook AP, et al. J Clin Oncol. 2000 Jul;18(14):2780-7. doi: 10.1200/JCO.2000.18.14.2780. J Clin Oncol. 2000. PMID: 10894879 Clinical Trial.

7

Colorectal metastases confined to the liver: a unique opportunity?

Venook AP. Venook AP. Semin Oncol. 2003 Aug;30(4 Suppl 15):34-9. doi: 10.1016/s0093-7754(03)00403-2. Semin Oncol. 2003. PMID: 14523793 Review.

8

A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863.

Venook AP, Enders Klein C, Fleming G, Hollis D, Leichman CG, Hohl R, Byrd J, Budman D, Villalona M, Marshall J, Rosner GL, Ramirez J, Kastrissios H, Ratain MJ. Venook AP, et al. Ann Oncol. 2003 Dec;14(12):1783-90. doi: 10.1093/annonc/mdg493. Ann Oncol. 2003. PMID: 14630685 Free article. Clinical Trial.

9

Cetuximab in the treatment of colorectal cancer.

Goldberg RM, Venook AP, Schilsky RL. Goldberg RM, et al. Among authors: venook ap. Clin Adv Hematol Oncol. 2004 Nov;2(11):1-10; quiz 11-12. Clin Adv Hematol Oncol. 2004. PMID: 16170891 No abstract available.

10

Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.

Ko AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero MA. Ko AH, et al. Among authors: venook ap. J Clin Oncol. 2006 Jan 20;24(3):379-85. doi: 10.1200/JCO.2005.01.8267. Epub 2005 Dec 12. J Clin Oncol. 2006. PMID: 16344320 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters